BAMS
NKTR icon

Bellevue Asset Management (Switzerland)’s Nektar Therapeutics NKTR Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.64M Sell
14,400
-1,600
-10% -$329K 0.55% 58
2015
Q3 		$2.65M Buy
16,000
+2,667
+20% +$472K 0.43% 72
2015
Q2 		$2.5M Buy
13,333
+5,600
+72% +$964K 0.35% 77
2015
Q1 		$1.28M Buy
+7,733
New +$1.59M 0.18% 111

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s NKTR Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Nektar Therapeutics (NKTR) stake by 10% in Q4 2015, selling an estimated $329K and leaving 14,400 shares worth $3.64M. The position accounts for 0.55% of the portfolio, ranked #58.

Bellevue Asset Management (Switzerland) first reported a position in NKTR in Q1 2015 and has held it in 4 quarters since. 179 funds tracked by Wall St. Rank hold NKTR as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 14,400 shares of Nektar Therapeutics worth $3.64M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 1,600 Nektar Therapeutics shares in Q4 2015, an estimated $329K.
  • Nektar Therapeutics made up 0.55% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #58 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Nektar Therapeutics in Q1 2015 and has held it in 4 quarters since.
  • 179 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.